CXCR1 correlates to poor outcomes of EGFR-TKI against advanced non-small cell lung cancer by activating chemokine and JAK/STAT pathway
Fang Yang, Shuai Zhang, Qingwei Meng, Fengrui Zhou, Bo Pan, Fang Liu, Yan Yu
Topics & Concepts
Cancer researchEpidermal growth factor receptorCXCL2Lung cancerChemokine receptorChemokineBiologyMedicineInternal medicineImmunologyImmune systemCancerChemokine receptors and signalingCytokine Signaling Pathways and InteractionsLung Cancer Treatments and Mutations